Skip to main content

Breadcrumb

  1. Home

National Committee for Quality Assurance

Care for Older Adults (COA) – Medication Review

  • Percentage of adults 65 years and older who had a medication review during the measurement year. A medication review is a review of all a patient’s medications, including prescription medications, over-the-counter (OTC) medications and herbal or supplemental therapies by a prescribing practitioner or clinical pharmacist.

    CBE ID
    0553

Cervical Cancer Screening

  • The percentage of women 21–64 years of age who were screened for cervical cancer using either of the following criteria:
    -Women 21–64 years of age who had cervical cytology performed within the last 3 years.
    -Women 30–64 years of age who had cervical high-risk human papillomavirus (hrHPV) testing performed within the last 5 years.
    -Women 30–64 years of age who had cervical cytology/high-risk human papillomavirus (hrHPV) cotesting within the last 5 years.

    CBE ID
    0032

Childhood Immunization Status (CIS)

  • Percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DtaP); three polio (IPV); one measles, mumps and rubella (MMR); three haemophilus influenza type B (HiB); three hepatitis B (HepB); one chicken pox (VZV); four pneumococcal conjugate (PCV); one hepatitis A (HepA); two or three rotavirus (RV); and two influenza (flu) vaccines by their second birthday. The measure calculates a rate for each vaccine.

    CBE ID
    0038

Chlamydia Screening and Follow Up

  • The percentage of female adolescents 18 years of age who had a chlamydia screening test with proper follow-up.

    CBE ID
    1395

Chlamydia Screening in Women (CHL)

  • The percentage of women 16–24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement year.

    CBE ID
    0033

Communication with the physician or other clinician managing on-going care post fracture for men and women aged 50 years and older

  • Percentage of adults 50 years and older treated for a fracture with documentation of communication, between the physician treating the fracture and the physician or other clinician managing the patient’s on-going care, that a fracture occurred and that the patient was or should be considered for osteoporosis treatment or testing. This measure is reported by the physician who treats the fracture and who therefore is held accountable for the communication.

    CBE ID
    0045

Comprehensive Diabetes Care

  • The percentage of patients 18–75 years of age with diabetes (type 1 and type 2) who had each of the following:
    - Hemoglobin A1c (HbA1c) testing (NQF#0057)
    - HbA1c poor control (>9.0%) (NQF#0059)
    - HbA1c control (<8.0%) (NQF#0575)
    - HbA1c control (<7.0%) for a selected population*
    - Eye exam (retinal) performed (NQF#0055)
    - LDL-C screening (NQF#0063)
    - LDL-C control (<100 mg/dL) (NQF#0064)
    - Medical attention for nephropathy (NQF#0062)
    - BP control (<140/90 mm Hg) (NQF#0061)
    - Smoking status and cessation advice or treatment

    CBE ID
    0731